New York State Common Retirement Fund
CGON icon

New York State Common Retirement Fund’s CG Oncology CGON Stock Holding History

New York State Common Retirement Fund’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
25,996
+8,200
+46% +$536K ﹤0.01% 1496
2026
Q1 		$1.2M Hold
17,796
– – ﹤0.01% 1595
2025
Q4 		$739K Hold
17,796
– – ﹤0.01% 1816
2025
Q3 		$717K Hold
17,796
– – ﹤0.01% 1810
2025
Q2 		$463K Buy
17,796
+3,800
+27% +$91.6K ﹤0.01% 1926
2025
Q1 		$343K Hold
13,996
– – ﹤0.01% 2016
2024
Q4 		$401K Buy
13,996
+2,000
+17% +$68.4K ﹤0.01% 2016
2024
Q3 		$453K Buy
11,996
+1,400
+13% +$49.1K ﹤0.01% 1973
2024
Q2 		$335K Buy
10,596
+3,596
+51% +$125K ﹤0.01% 2205
2024
Q1 		$307K Buy
+7,000
New +$286K ﹤0.01% 2273

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

New York State Common Retirement Fund's CGON Position: Q2 2026 in Review

New York State Common Retirement Fund increased its CG Oncology (CGON) stake by 46% in Q2 2026, buying an estimated $536K and bringing the position to 25,996 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

New York State Common Retirement Fund first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • New York State Common Retirement Fund held 25,996 shares of CG Oncology worth $1.85M as of Q2 2026.
  • New York State Common Retirement Fund bought 8,200 CG Oncology shares in Q2 2026, an estimated $536K.
  • CG Oncology made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1496 holding.
  • New York State Common Retirement Fund first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.